2002
DOI: 10.1016/s0040-4039(02)01394-1
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of 2-amino-6-(2-[18F]fluoro-pyridine-4-ylmethoxy)-9-(octyl-β-d-glucosyl)-purine: a novel radioligand for positron emission tomography studies of the O6-methylguanine-DNA methyltransferase (MGMT) status of tumour tissue

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2005
2005
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(8 citation statements)
references
References 9 publications
0
8
0
Order By: Relevance
“…[8][9][10][11][12] A uorine-18 labelled pyridine tracer designed for the PET imaging of O 6 -methylguanine-DNA methyltransferase (MGMT) status of tumour tissues, 2amino-6-(2-[ 18 F]uoropyridine-4-ylmethoxy)-9-(octyl-b-Dglucosyl)-purine, was also synthesised in only 5% RCY. 13 Given these difficulties associated with uorine-18 labeling pyridinecontaining structures, it was hypothesized that a rhenium(I) activated approach could be a powerful tool towards expanding the scope of such radiotracers. 14 To test this hypothesis, we selected three common bidentate structures throughout our investigation; 1,10-phenanthroline, 2,2 0 -bipyridine and 8hydroxyquinoline.…”
Section: Introductionmentioning
confidence: 99%
“…[8][9][10][11][12] A uorine-18 labelled pyridine tracer designed for the PET imaging of O 6 -methylguanine-DNA methyltransferase (MGMT) status of tumour tissues, 2amino-6-(2-[ 18 F]uoropyridine-4-ylmethoxy)-9-(octyl-b-Dglucosyl)-purine, was also synthesised in only 5% RCY. 13 Given these difficulties associated with uorine-18 labeling pyridinecontaining structures, it was hypothesized that a rhenium(I) activated approach could be a powerful tool towards expanding the scope of such radiotracers. 14 To test this hypothesis, we selected three common bidentate structures throughout our investigation; 1,10-phenanthroline, 2,2 0 -bipyridine and 8hydroxyquinoline.…”
Section: Introductionmentioning
confidence: 99%
“…The idea of glucose conjugation of AGT inhibitors [23] was continued [33] to deliver the pharmaceutical specifically to the tumor tissue via the over-expressed glucose transporters. Radioactive labeling was conducted to prove the concept of targeting in general as well as to quantify the AGT level non-invasively in vivo by positron emission tomography (PET).…”
Section: Isotopically Labeled O 6 -Substituted Guaninesmentioning
confidence: 99%
“…Other methods for the introduction of alkyloxy or aryloxy substituents in the purine structure involve substitution reactions of different leaving groups such as: 1) benzotriazolyloxy group (HOBT) [8,[29][30][31][32]; 2) the alkylimidazolyl group [33,34] and 3) in-situ-generated alkylammonia salts [35][36][37][38]. In 1995, the Robins group demonstrated S N Ar reactions of 6-(1,2,4triazol-4-yl)purine with dimethylamine, sodium methoxide and sodium thiomethoxide [39].…”
Section: Introductionmentioning
confidence: 99%